Kristen rat sarcoma virus (KRAS oncogene) mutations are often seen in human cancer, and ganetespib has been shown to effectively inhibit HSP90, affecting the constitutive activation of several signaling transduction pathways, including Ras/Raf/MEK/ERK signaling components. This evidence concerns the gene MAP2K7 and cancer.